WHO’s Global Advisory Committee on Vaccine Safety systematically reviews any vaccine safety signals and concerns related to COVID-19 vaccine safety
- As of March 9, over 268 million doses of COVID-19 vaccines have been administered worldwide since the start of the pandemic
- No cases of death have been found to have been caused by COVID-19 vaccines to date
- Vaccination against COVID-19 will not reduce deaths from other causes
The World Health Organization (WHO) today commented on Denmark, Iceland, Italy and Norway suspending the use of the AstraZeneca vaccine after reports of thrombosis among those vaccinated.
According to the world’s health body, over 268 million people have been vaccinated against COVID-19 globally, and no deaths from the vaccines have been confirmed as of March 9.
“WHO is aware that as a precautionary measure, a few countries in the European Union have suspended use of a specific batch of AstraZeneca vaccine distributed in the EU, based on reports of rare blood coagulation disorders in persons who had received vaccine from that particular batch. This was decided as a precaution whilst a full investigation is finalized,” WHO Spokesperson Tarik Jasarevic said.
“It is important to note that the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee position is that the vaccine’s benefits continue to outweigh its risks, and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing,” the spokesperson said.
“WHO’s Global Advisory Committee on Vaccine Safety (GACVS) systematically reviews any vaccine safety signals and concerns related to COVID-19 vaccine safety, and meets every two weeks to advise WHO on any new safety signals or concerns related to COVID-19 vaccines,” he added.
“The GACVS is carefully assessing the current reports on the Astra Zeneca vaccine. As soon as WHO has gained a full understanding of these events, the findings and any changes to current recommendations will be immediately communicated to the public. Vaccination against COVID-19 will not reduce deaths from other causes. Deaths from other causes will continue to occur, including after vaccination, but causally unrelated,” Jasarevic said.
It was reported on Thursday that Denmark and a number of other states had suspended the use of the AstraZeneca vaccine after reports of thrombosis among those vaccinated. Earlier, the European Medicines Agency (EMA) recommended to continue using the vaccine, noting that it has not been proven that these symptoms were caused by vaccination. According to the EMA, as of March 10, there were 30 cases of thromboembolic complications among about 5 mln people who were administered the AstraZeneca vaccine. The agency stressed that this means that the number of reported side effects among those vaccinated does not surpass the number of such cases in the population on the whole.
